CCR3 RECEPTOR ANTAGONISTS

The present invention relates to compounds of Formula (I), wherein R , R , R , R , Ar, UC, X, Y, Q, n and p are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for treatment of CCR-3 mediated diseases. La présente invention concerne...

Full description

Saved in:
Bibliographic Details
Main Authors GONG, LEYI, WILHELM, ROBERT, STEPHEN
Format Patent
LanguageEnglish
French
Published 23.06.2005
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of Formula (I), wherein R , R , R , R , Ar, UC, X, Y, Q, n and p are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for treatment of CCR-3 mediated diseases. La présente invention concerne des composés de formule (I), dans laquelle R , R , R , R , Ar, UC, X, Y, Q, n et p sont tels que définis dans le mémorandum descriptif. Ces composés sont utiles comme antagonistes du récepteur CCR-3, et peuvent donc être employés pour le traitement de maladies induites par CCR-3.
Bibliography:Application Number: WO2004EP11545